MedPath
Found 1 clinical trials|View Analysis
Sort by:

Autologous Dendritic Cell Vaccine in Kidney Cancer

Phase 2
Recruiting
Conditions
Carcinoma, Renal Cell
Interventions
Biological: Autologous alpha-DC1/TBVA vaccine
Drug: Cabozantinib
First Posted Date
2021-11-19
Last Posted Date
2024-12-12
Lead Sponsor
Jodi Maranchie
Target Recruit Count
42
Registration Number
NCT05127824
Locations
🇺🇸

UPMC Department of Urology, Pittsburgh, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath